A Beijing medical group arranging cell and gene therapies for blood cancers and other diseases, working through treatment centres across China and taking enquiries from abroad.
Bioocus is a Beijing-based medical group working in cell and gene therapy. It describes itself as a company with its own research centre and a technology transfer platform, and states that it operates through a number of treatment centres across China. Its main audience appears to be patients with blood cancers and certain genetic blood disorders.
The treatments named are largely established or trial-stage cancer therapies rather than the kind of stem cell injection offered by wellness clinics: CAR-T cell therapy, in which a patient's own immune cells are genetically modified to attack cancer; tumour-infiltrating lymphocyte therapy; natural killer cell therapy; gene therapy for thalassaemia and sickle cell disease; oncolytic virus therapy; and ablation procedures using heat or extreme cold. Nusinersen sodium, a licensed drug for spinal muscular atrophy, is also listed.
The company states that more than 1,600 CAR-T patients have been enrolled. That figure is published by the company itself and has not been independently verified. It also says it works in more than fifty countries and supports enquiries in a wide range of languages by telephone, WhatsApp and WeChat.
Most of the conditions listed are cancers or serious blood disorders. Treatments of this kind are usually given under specialist oncology supervision, so ask how the proposed treatment compares with what is available at home.
The registered address is Room B584, Building 14, Cui Wei Zhong Li, Haidian District, Beijing, China, and the company lists further treatment centres across China. It states that it works in more than fifty countries and handles international enquiries by telephone, WhatsApp and WeChat. The year the company was founded is not published.
No prices are published. Cell and gene therapies of this type are typically very costly, so obtain a full written quotation, including hospital stay and follow-up, before making any commitment.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.